Oculis Holding AG ( OCS) - Stock Earnings
OCS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -21.2 million USD | 305120 USD |
| 2025Q4 | -29.4 million USD | — USD |
| 2026Q1 | -36.8 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
OCS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -105.6 million USD | 1.1 million USD |
| 2024 | -94.9 million USD | 758581 USD |
| 2025 | -119.1 million USD | — USD |
| 2026 Est. | — | — |
OCS
Price: $11.09
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Market Capitalization: 735.8 million